Literature DB >> 17492684

New measure of health-related quality of life for patients with oropharyngeal mucositis: development and preliminary psychometric evaluation.

Karis K F Cheng1, S F Leung, David R Thompson, Josepha W M Tai, Raymond H S Liang, Alta S T Kan, Fion W O Ying, Rebecca M W Yeung.   

Abstract

BACKGROUND: Oropharyngeal mucositis (OM) causes profound impairment of patients' health-related quality of life (HQoL). The aim of the article is to describe the development and preliminary validation of an HQoL instrument, OMQoL, specifically for patients with OM.
METHODS: First, a qualitative phase was conducted to generate items (n = 23). Face validity was assessed by focus group interviews (n = 13). Expert content review (n = 7) was used to ensure content validity. The second step was a quantitative validation phase comprised a multicenter study (n = 210) to help identify subscales of the instrument addressing different dimensions of OM and to measure reliability.
RESULTS: The qualitative interview generated 171 items. Using focus group discussion and expert content review, items were reduced to 41 items. Factor and scaling analyses of these 41 items resulted in 4 subscales, contributed by 31 items, depicting problems with symptoms, diet, social function, and swallowing. The floor effect was modest. The factorial structure was satisfactory with loading >0.40 on each subscale for all items. All corrected item-total corrections were higher than 0.40 (r = 0.457-0.874). The internal consistency reliability of each subscale was high, with Cronbach alpha coefficients ranging from 0.906 to 0.934. The test-retest reliability of the individual items using weighted kappa was good (kappa values 0.610-0.895). The intraclass correlation results for the subscale totals were all in excess of 0.70 (0.864-0.934).
CONCLUSIONS: An initial psychometric analysis of the OMQoL was encouraging. The OMQoL could provide a valuable tool for the assessment of HQoL of patients with OM. Copyright 2007 American Cancer Society.

Entities:  

Mesh:

Year:  2007        PMID: 17492684     DOI: 10.1002/cncr.22730

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Assessment of indomethacin oral spray for the treatment of oropharyngeal mucositis-induced pain during anticancer therapy.

Authors:  Kenji Momo; Hiroka Nagaoka; Yoshiyuki Kizawa; Hiroki Bukawa; Shigeru Chiba; Yukinao Kohda; Masato Homma
Journal:  Support Care Cancer       Date:  2017-07-15       Impact factor: 3.603

2.  A patient-reported outcome instrument to assess the impact of oropharyngeal mucositis on health-related quality of life: a longitudinal psychometric evaluation.

Authors:  Karis K F Cheng; S F Leung; Raymond H S Liang; Josepha W M Tai; Rebecca M W Yeung; David R Thompson
Journal:  Support Care Cancer       Date:  2008-08-02       Impact factor: 3.603

3.  Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life.

Authors:  Karis Kin-Fong Cheng; S F Leung; Raymond H S Liang; Josepha W M Tai; Rebecca M W Yeung; David R Thompson
Journal:  Support Care Cancer       Date:  2009-11-15       Impact factor: 3.603

4.  Development and validation of an instrument to measure patient engagement in Hong Kong Special Administrative Region, China.

Authors:  Richard Huan Xu; Annie Wai-Ling Cheung; Eliza Lai-Yi Wong
Journal:  Patient Prefer Adherence       Date:  2018-09-04       Impact factor: 2.711

5.  Validity and reliability of the Persian version of the oropharyngeal Mucositis quality of life scale.

Authors:  Fatemeh Sadat Hasheminasab; Mona Pourpasha; Azizallah Dehghan; Mahboubeh Yari Galousalari; Seyed Mehdi Hashemi; Mohammad Setayesh
Journal:  BMC Oral Health       Date:  2021-11-23       Impact factor: 2.757

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.